Clinical Trials Directory

Trials / Completed

CompletedNCT00846651

Spinal Anesthesia Induced Hypotension During Cesarean Section

Comparison of Phenylephrine Infusion With Colloids vs. Crystalloids for Reduction of Spinal-induced Hypotension During Cesarean Section

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare two methods for preventing low blood pressure associated with spinal anesthesia during Cesarean sections.

Detailed description

Many women experience low blood pressure after spinal anesthesia for Cesarean section. This low blood pressure may result in nausea, vomiting dizziness and impairment of uterine blood flow.The purpose of this study is to compare two methods for preventing low blood pressure associated with spinal anesthesia during Cesarean sections. In both methods, we will attempt to prevent low blood pressure using phenylephrine infusion that has been shown to be effective in recent research. In addition to receiving phenylephrine one group of patients will receive standard salt solution (Ringer's lactate solution), while the other group will receive a different, intravenous fluid called hydroxyethylstarch.

Conditions

Interventions

TypeNameDescription
OTHERColloid administrationThe patients received 0.5 L colloid solution (hydroxyethylstarch 6%) or 1.5 L Ringer lactate prior to spinal anesthesia for cesarean section.
OTHERCrystalloid administrationThe patients received 1.5 L Ringer lactate prior to spinal anesthesia for cesarean section.
DRUGphenylephrine infusionA phenylephrine infusion will be started immediately after performing the spinal anesthesia and continued until time of uterine incision.

Timeline

Start date
2009-02-01
Primary completion
2009-12-01
Completion
2010-02-01
First posted
2009-02-19
Last updated
2017-10-16
Results posted
2013-07-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00846651. Inclusion in this directory is not an endorsement.